Business Wire

MariaDB to Acquire GridGain: Architecting the Real-Time Foundation for the Agentic Enterprise

9.3.2026 14:00:00 CET | Business Wire | Press release

Share

Strategic acquisition unites MariaDB’s mission-critical relational database with GridGain’s extreme in-memory speed to power the next generation of AI applications

MariaDB plc today announced that it has entered into a definitive agreement to acquire GridGain Systems, Inc., the pioneer of in-memory computing and creator of open source Apache Ignite. By merging MariaDB’s AI-ready relational database with GridGain’s scalable, in-memory power, MariaDB is setting a new industry standard: sub-millisecond data infrastructure for the agentic era.

Closing the AI Latency Gap

As enterprises move beyond passive chatbots toward agentic AI – autonomous systems that reason, plan and execute tasks – they are quickly becoming limited by traditional data architectures. AI agents require real-time access to massive datasets with zero friction. This acquisition bridges that gap by fusing:

  • MariaDB’s reliability: Proven, ACID-compliant transactional integrity for the world’s most sensitive data, with native vector capability and AI support.
  • GridGain’s speed: Extreme-scale and in-memory processing that eliminates the disk-drive tax on performance.

“The rise of agentic workloads has placed unprecedented demands on enterprise infrastructure, causing requirements to explode and requiring a level of scale and sub-millisecond latency that traditional systems simply weren’t built to handle,” said Rohit de Souza, CEO of MariaDB plc. “By uniting MariaDB’s platform with GridGain’s in-memory data grid, we are entering a new weight class. This enables us to provide a high-performance, scalable, open alternative to the rigid lock-in of Oracle and the fragmented complexity of hyperscalers.”

MariaDB is trusted by thousands of enterprises and millions of developers worldwide, providing a seamless upgrade path from Oracle MySQL and a simplified migration for those moving away from Oracle.

Powering the World’s Premier Data-Intensive Brands

With the acquisition, MariaDB will support an elite roster of global leaders who require always-on, always-fast data, including:

  • Financial services: American Express, Barclays, BNP Paribas, Citi, DBS, Deutsche Bank, RBC and State Street Corporation.
  • Technology: HPE, Motorola Solutions and Red Hat.
  • Telecommunications: Nokia, Optiva, Reliance Jio, Telecom Italia, Verizon and Virgin Media O2.
  • Logistics and services: American Airlines, UPS, XPO Logistics and 24 Hour Fitness.

A Unified Platform for a Hybrid World

The agentic enterprise requires data that is instantaneous without compromising on durability or reliability. Hyperscalers often offer this as separate, disconnected services. The MariaDB-plus-GridGain integration will replace that fragmentation with a unified, hybrid-cloud platform capable of handling transactional, analytical and AI use cases in a single, high-velocity system – backed by reliable, enterprise support from a single company.

“Enterprises today cannot afford the latency introduced by siloed data architectures. With MariaDB and GridGain, enterprise customers will get a unified platform that provides them the best of both worlds, performance and scale without having to give up on durability,” says Lalit Ahuja, CTO of GridGain Systems, Inc. “The combined technology stack will unlock one of the key enablers for agentic enterprises: high-performance and reliable data processing that powers the next generation of AI applications.”

GridGain is a leading in-memory computing platform and is the original developer of the open source software Apache Ignite. GridGain enables companies to process massive amounts of data in real time. It provides security, high availability, distributed capability, management controls and integrations, helping enterprises achieve superior performance and scalability for their most demanding applications.

The transaction is subject to customary closing conditions.

About MariaDB

MariaDB seeks to eliminate the constraints and complexity of proprietary databases, enabling organizations to reinvest in what matters most – rapidly developing innovative, customer-facing applications. Enterprises can depend on a single complete hybrid database platform for all their needs, that can be deployed in minutes for transactional, analytical, hybrid and AI use cases. Trusted by organizations such as Deutsche Bank, DBS, Nokia, Red Hat, Samsung and VirginMedia O2 – MariaDB delivers customer value without the financial burden of legacy database providers. For more information, please visit mariadb.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260309333727/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye